Physiological glucose is critical for optimized neuronal viability and AMPK responsiveness in vitro

Journal of Neuroscience Methods

Volumn 167, Issue 2, 2008, Pages 292-301

  Kleman, Amy M ^a   Yuan, Jason Y ^a   Aja, Susan ^a   Ronnett, Gabriele V ^a   Landree, Leslie E ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

AICAR; AMP activated protein kinase; ATP; C75; Neuronal culture; Physiological glucose

Indexed keywords

GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE;

ANIMAL CELL; ARTICLE; CELL METABOLISM; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; ENERGY BALANCE; ENERGY METABOLISM; METABOLIC STRESS; NERVE CELL CULTURE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; SPRAGUE DAWLEY RAT;

4-BUTYROLACTONE; ADENOSINE TRIPHOSPHATE; AMINOIMIDAZOLE CARBOXAMIDE; ANALYSIS OF VARIANCE; ANIMALS; CELL SURVIVAL; CELLS, CULTURED; CEREBRAL CORTEX; DOSE-RESPONSE RELATIONSHIP, DRUG; EMBRYO, MAMMALIAN; GLUCOSE; HYPOGLYCEMIC AGENTS; MULTIENZYME COMPLEXES; NEURONS; PROTEIN-SERINE-THREONINE KINASES; RATS; RATS, SPRAGUE-DAWLEY; RIBONUCLEOTIDES; TIME FACTORS;

EID: 36849019542     PISSN: 01650270     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneumeth.2007.08.028     Document Type: Article

References (61)

1. Abe T., Takahashi S., and Suzuki N. Oxidative metabolism in cultured rat astroglia: effects of reducing the glucose concentration in the culture medium and of d-aspartate or potassium stimulation. J Cereb Blood Flow Metab 26 (2006) 153-160
2. Abi-Saab W.M., Maggs D.G., Jones T., Jacob R., Srihari V., Thompson J., et al. Striking differences in glucose and lactate levels between brain extracellular fluid and plasma in conscious human subjects: effects of hyperglycemia and hypoglycemia. J Cereb Blood Flow Metab 22 (2002) 271-279
3. Andersson U., Filipsson K., Abbott C.R., Woods A., Smith K., Bloom S.R., et al. Amp-activated protein kinase plays a role in the control of food intake. J Biol Chem 279 (2004) 12005-12008
4. Bak L.K., Schousboe A., Sonnewald U., and Waagepetersen H.S. Glucose is necessary to maintain neurotransmitter homeostasis during synaptic activity in cultured glutamatergic neurons. J Cereb Blood Flow Metab 26 (2006) 1285-1297
5. Boileau P., Mrejen C., Girard J., and Hauguel-de Mouzon S. Overexpression of glut3 placental glucose transporter in diabetic rats. J Clin Invest 96 (1995) 309-317
6. Bouzier-Sore A.K., Voisin P., Canioni P., Magistretti P.J., and Pellerin L. Lactate is a preferential oxidative energy substrate over glucose for neurons in culture. J Cereb Blood Flow Metab 23 (2003) 1298-1306
7. Canabal D.D., Song Z., Potian J.G., Beuve A., McArdle J.J., and Routh V.H. Glucose, insulin, and leptin signaling pathways modulate nitric oxide synthesis in glucose-inhibited neurons in the ventromedial hypothalamus. Am J Physiol Regul Integr Comp Physiol 292 (2007) R1418-R1428
8. Canabal D.D., Potian J.G., Duran R.G., McArdle J.J., and Routh V.H. Hyperglycemia impairs glucose and insulin regulation of nitric oxide production in glucose-inhibited neurons in the ventromedial hypothalamus. Am J Physiol Regul Integr Comp Physiol 293 (2007) R592-R600
9. Carling D. The amp-activated protein kinase cascade-a unifying system for energy control. Trends Biochem Sci 29 (2004) 18-24
10. Carling D. Amp-activated protein kinase: balancing the scales. Biochimie 87 (2005) 87-91
11. Chau-Van C., Gamba M., Salvi R., Gaillard R.C., and Pralong F.P. Metformin inhibits adenosine 5′-monophosphate-activated kinase activation and prevents increases in neuropeptide and expression in cultured hypothalamic neurons. Endocrinology 148 (2007) 507-511
12. Chen M.B., McAinch A.J., Macaulay S.L., Castelli L.A., O'Brien P.E., Dixon J.B., et al. Impaired activation of amp-kinase and fatty acid oxidation by globular adiponectin in cultured human skeletal muscle of obese type 2 diabetics. J Clin Endocrinol Metab 90 (2005) 3665-3672
13. Clough-Helfman C., and Phillis J.W. 5-Aminoimidazole-4-carboxamide riboside (AICAR) administration reduces cerebral ischemic damage in the Mongolian gerbil. Brain Res Bull 25 (1990) 203-206
14. Cryer P.E. Hypoglycemia-associated autonomic failure in diabetes. Am J Physiol Endocrinol Metab 281 (2001) E1115-E1121
15. Culmsee C., Monnig J., Kemp B.E., and Mattson M.P. Amp-activated protein kinase is highly expressed in neurons in the developing rat brain and promotes neuronal survival following glucose deprivation. J Mol Neurosci 17 (2001) 45-58
16. Dasgupta B., and Milbrandt J. Resveratrol stimulates amp kinase activity in neurons. Proc Natl Acad Sci USA 104 (2007) 7217-7222
17. Dawson T.M., Arriza J.L., Lefkowitz R.J., Jaworsky D.E., and Ronnett G.V. Beta-adrenergic receptor kinase-2 and beta-arrestin-2: mediators of odorant-induced desensitization. Science 259 (1993) 825-829
18. de Vries M.G., Arseneau L.M., Lawson M.E., and Beverly J.L. Extracellular glucose in rat ventromedial hypothalamus during acute and recurrent hypoglycemia. Diabetes 52 (2003) 2767-2773
19. Fujii N., Jessen N., and Goodyear L.J. Amp-activated protein kinase and the regulation of glucose transport. Am J Physiol Endocrinol Metab 291 (2006) E867-E877
20. Gao G., Fernandez C.S., Stapleton D., Auster A.S., Widmer J., Dyck J.R., et al. Non-catalytic beta- and gamma-subunit isoforms of the 5′-amp-activated protein kinase. J Biol Chem 271 (1996) 8675-8681
21. Hardie D.G. Roles of the amp-activated/snf1 protein kinase family in the response to cellular stress. Biochem Soc Symp 64 (1999) 13-27
22. Hardie D.G. The amp-activated protein kinase pathway-new players upstream and downstream. J Cell Sci 117 (2004) 5479-5487
23. Hardie D.G., and Carling D. The amp-activated protein kinase-fuel gauge of the mammalian cell?. Eur J Biochem 246 (1997) 259-273
24. Hardie D.G., Scott J.W., Pan D.A., and Hudson E.R. Management of cellular energy by the amp-activated protein kinase system. FEBS Lett 546 (2003) 113-120
25. Ioudina M., Uemura E., and Greenlee H.W. Glucose insufficiency alters neuronal viability and increases susceptibility to glutamate toxicity. Brain Res 1004 (2004) 188-192
26. Kang L., Dunn-Meynell A.A., Routh V.H., Gaspers L.D., Nagata Y., Nishimura T., et al. Glucokinase is a critical regulator of ventromedial hypothalamic neuronal glucosensing. Diabetes 55 (2006) 412-420
27. Kim M.S., and Lee K.U. Role of hypothalamic 5′-amp-activated protein kinase in the regulation of food intake and energy homeostasis. J Mol Med 83 (2005) 514-520
28. Kim E.K., Miller I., Aja S., Landree L.E., Pinn M., McFadden J., et al. C75, a fatty acid synthase inhibitor, reduces food intake via hypothalamic amp-activated protein kinase. J Biol Chem 279 (2004) 19970-19976
29. Kim M.S., Park J.Y., Namkoong C., Jang P.G., Ryu J.W., Song H.S., et al. Anti-obesity effects of alpha-lipoic acid mediated by suppression of hypothalamic amp-activated protein kinase. Nat Med 10 (2004) 727-733
30. Kola B., Hubina E., Tucci S.A., Kirkham T.C., Garcia E.A., Mitchell S.E., et al. Cannabinoids and ghrelin have both central and peripheral metabolic and cardiac effects via amp-activated protein kinase. J Biol Chem 280 (2005) 25196-25201
31. Landree L.E., Hanlon A.L., Strong D.W., Rumbaugh G., Miller I.M., Thupari J.N., et al. C75, a fatty acid synthase inhibitor, modulates amp-activated protein kinase to alter neuronal energy metabolism. J Biol Chem 279 (2004) 3817-3827
32. Lee K., Li B., Xi X., Suh Y., and Martin R.J. Role of neuronal energy status in the regulation of adenosine 5′-monophosphate-activated protein kinase, orexigenic neuropeptides expression, and feeding behavior. Endocrinology 146 (2005) 3-10
33. Levin B.E., Dunn-Meynell A.A., and Routh V.H. Brain glucose sensing and body energy homeostasis: role in obesity and diabetes. Am J Physiol 276 (1999) R1223-R1231
34. Lo E.H., Dalkara T., and Moskowitz M.A. Mechanisms, challenges and opportunities in stroke. Nat Rev Neurosci 4 (2003) 399-415
35. Magistretti P.J., and Pellerin L. Astrocytes couple synaptic activity to glucose utilization in the brain. News Physiol Sci 14 (1999) 177-182
36. Maher F., Vannucci S.J., and Simpson I.A. Glucose transporter proteins in brain. FASEB J 8 (1994) 1003-1011
37. Martin T.L., Alquier T., Asakura K., Furukawa N., Preitner F., and Kahn B.B. Diet-induced obesity alters amp kinase activity in hypothalamus and skeletal muscle. J Biol Chem 281 (2006) 18933-18941
38. McCullough L.D., Zeng Z., Li H., Landree L.E., McFadden J., and Ronnett G.V. Pharmacological inhibition of amp-activated protein kinase provides neuroprotection in stroke. J Biol Chem 280 (2005) 20493-20502
39. Merriman-Smith B.R., Krushinsky A., Kistler J., and Donaldson P.J. Expression patterns for glucose transporters glut1 and glut3 in the normal rat lens and in models of diabetic cataract. Invest Ophthalmol Vis Sci 44 (2003) 3458-3466
40. Minokoshi Y., Alquier T., Furukawa N., Kim Y.B., Lee A., Xue B., et al. Amp-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus. Nature 428 (2004) 569-574
41. Mokdad A.H., Bowman B.A., Ford E.S., Vinicor F., Marks J.S., and Koplan J.P. The continuing epidemics of obesity and diabetes in the United States. JAMA 286 (2001) 1195-1200
42. Morgan K., Obici S., and Rossetti L. Hypothalamic responses to long-chain fatty acids are nutritionally regulated. J Biol Chem 279 (2004) 31139-31148
43. Morgenthaler F.D., Kraftsik R., Catsicas S., Magistretti P.J., and Chatton J.Y. Glucose and lactate are equally effective in energizing activity-dependent synaptic vesicle turnover in purified cortical neurons. Neuroscience 141 (2006) 157-165
44. Mountjoy P.D., Bailey S.J., and Rutter G.A. Inhibition by glucose or leptin of hypothalamic neurons expressing neuropeptide and requires changes in amp-activated protein kinase activity. Diabetologia 50 (2007) 168-177
45. Nagamatsu S., Sawa H., Inoue N., Nakamichi Y., Takeshima H., and Hoshino T. Gene expression of glut3 glucose transporter regulated by glucose in vivo in mouse brain and in vitro in neuronal cell cultures from rat embryos. Biochem J 300 Pt 1 (1994) 125-131
46. Pierre K., and Pellerin L. Monocarboxylate transporters in the central nervous system: distribution, regulation and function. J Neurochem 94 (2005) 1-14
47. Routh V.H. Glucose-sensing neurons: Are they physiologically relevant?. Physiol Behav 76 (2002) 403-413
48. Routh V.H., Song Z., and Liu X. The role of glucosensing neurons in the detection of hypoglycemia. Diabet Technol Ther 6 (2004) 413-421
49. Sango K., Horie H., Sotelo J.R., and Takenaka T. A high glucose environment improves survival of diabetic neurons in culture. Neurosci Lett 129 (1991) 277-280
50. Sango K., Horie H., Takano M., Inoue S., and Takenaka T. Diabetes-induced reduction of neuronal survival in hypotonic environments in culture. Brain Res Bull 34 (1994) 365-368
51. Schwartz M.W., Baskin D.G., Bukowski T.R., Kuijper J.L., Foster D., Lasser G., et al. Specificity of leptin action on elevated blood glucose levels and hypothalamic neuropeptide and gene expression in ob/ob mice. Diabetes 45 (1996) 531-535
52. Silver I.A., and Erecinska M. Extracellular glucose concentration in mammalian brain: continuous monitoring of changes during increased neuronal activity and upon limitation in oxygen supply in normo-, hypo-, and hyperglycemic animals. J Neurosci 14 (1994) 5068-5076
53. Somoza B., Guzman R., Cano V., Merino B., Ramos P., Diez-Fernandez C., et al. Induction of cardiac uncoupling protein-2 expression and adenosine 5′-monophosphate-activated protein kinase phosphorylation during early states of diet-induced obesity in mice. Endocrinology 148 (2007) 924-931
54. Song Z., and Routh V.H. Differential effects of glucose and lactate on glucosensing neurons in the ventromedial hypothalamic nucleus. Diabetes 54 (2005) 15-22
55. Song Z., and Routh V.H. Recurrent hypoglycemia reduces the glucose sensitivity of glucose-inhibited neurons in the ventromedial hypothalamus nucleus. Am J Physiol Regul Integr Comp Physiol 291 (2006) R1283-R1287
56. Stapleton D., Mitchelhill K.I., Gao G., Widmer J., Michell B.J., Teh T., et al. Mammalian amp-activated protein kinase subfamily. J Biol Chem 271 (1996) 611-614
57. Turnley A.M., Stapleton D., Mann R.J., Witters L.A., Kemp B.E., and Bartlett P.F. Cellular distribution and developmental expression of amp-activated protein kinase isoforms in mouse central nervous system. J Neurochem 72 (1999) 1707-1716
58. Wang R., Liu X., Hentges S.T., Dunn-Meynell A.A., Levin B.E., Wang W., et al. The regulation of glucose-excited neurons in the hypothalamic arcuate nucleus by glucose and feeding-relevant peptides. Diabetes 53 (2004) 1959-1965
59. Wang D., and Sul H. Insulin stimulation of the fatty acid synthase promoter is mediated by the phosphatidylinositol 3-kinase pathway. J Biol Chem 273 (1998) 25420-25426
60. Winder W.W. Amp-activated protein kinase: possible target for treatment of type 2 diabetes. Diabet Technol Ther 2 (2000) 441-448
61. Wortman M.D., Clegg D.J., D'Alessio D., Woods S.C., and Seeley R.J. C75 inhibits food intake by increasing CNS glucose metabolism. Nat Med 9 (2003) 483-485